Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal

Completion of the deal is anticipated towards the end of 2026.

Latest news

UK biotech financing continues recovery trajectory on five-year Q2 high

While UK biotech financing recovery is present in the private markets, BIA CEO Chris Molloy notes that UK public sector backing is essential for sustained growth.

Novartis and Takeda drugs gain rare blood cancer routine use on NHS

The therapies’ availability will offer a route to personalised, mutation-specific approaches for types of rare blood cancers.

Aptar unveils framework for injectable drug delivery systems

The framework combines Aptar Pharma’s elastomeric experience and a network of partners across the injectable drugs sector.

Bayer’s heart failure drug bound for NHS on NICE recommendation

Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

JCVI issues recommendation on adolescent MenB vaccination in UK

The JCVI review incorporated recent data on the effectiveness in adolescents vaccinated against MenB in infancy.